Pernix Therapeutics (PTX) Earnings
|
Expand Research on PTX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1,450.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -11.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/10/16 | Q316 | -$2.99 | N/A | N/A | $41.5M | $48.6M | N/A | ![]() | ![]() | Details | |
| 8/11/16 |
Q216 | -$0.47 | N/A | N/A | $36.75M | $46.98M | N/A | ![]() | ![]() | Details | |
| 5/5/16 |
Q116 | -$0.42 | -$0.06 | -$0.36 | $32.5M | $44.55M | N/A | ![]() | ![]() | Details | |
| 11/5/15 |
Q315 | -$0.18 | $0.01 | -$0.19 | $48.6M | $46.83M | N/A | ![]() | ![]() | Details | |
| 8/6/15 |
Q215 | -$0.10 | $0.05 | -$0.15 | $47M | $50.7M | N/A | ![]() | ![]() | Details | |
| 5/1/15 |
Q115 | -$0.62 | -$0.02 | -$0.60 | $33.9M | $34.55M | N/A | ![]() | ![]() | Details | |
| 2/25/15 | Q414 | $0.25 | $0.18 | +$0.07 | $53M | $52.7M | N/A | ![]() | ![]() | Details | |
| 11/10/14 | Q314 | -$0.02 | $0.00 | -$0.02 | $31.5M | $28.1M | N/A | ![]() | ![]() | Details |

